Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
Deferasirox Impacts Myeloid Differentiation via NF-κB and Mi
2026-07-20
This study reveals that Deferasirox, a clinically used iron chelator, modulates myeloid differentiation through stage-specific effects on mitochondrial reactive oxygen species and NF-κB pathway activity. These findings clarify the non-linear relationship between iron chelation, oxidative signaling, and hematopoietic cell fate, with implications for both iron overload treatment research and the biology of myelodysplastic syndromes.
-
Ferrostatin-1 (Fer-1): Optimizing Ferroptosis Assays in Dise
2026-07-20
Ferrostatin-1 (Fer-1) empowers researchers to dissect ferroptosis in cancer, neurodegeneration, and inflammatory settings with nanomolar precision. This article details experimental workflows, troubleshooting strategies, and protocol optimizations grounded in the latest mechanistic and translational insights.
-
Dissecting Drug Responses in Cancer: Insights from In Vitro
2026-07-19
Schwartz's dissertation addresses a critical gap in cancer pharmacology by distinguishing between proliferation arrest and cell death in drug response assays. Her work introduces a refined analytical framework that improves the precision of in vitro evaluation of anti-cancer agents, with implications for experimental design and interpretation in cancer chemotherapy research.
-
Hoechst 33342 Nuclear Stain: Powering Skin Aging Research
2026-07-18
Explore how APExBIO's Hoechst 33342 Solution (1 mg/mL) is reshaping live cell nuclear staining and advancing translational research in skin aging, bridging mechanistic insight with workflow innovation, and highlighting its role in the context of mitochondrial quality control and fibroblast senescence studies.
-
UTP Solution: Precision Uridine-5'-Triphosphate for RNA Rese
2026-07-17
UTP Solution (100 mM) empowers high-yield, reproducible in vitro transcription, siRNA synthesis, and carbohydrate metabolism studies. Its ultrapure, DNase/RNase-free formulation, as supplied by APExBIO, ensures experimental sensitivity and reliability—especially in workflows demanding stringent nucleotide quality.
-
Dextrose (D-glucose): Powering Immunometabolism Research
2026-07-17
Explore how Dextrose (D-glucose) enables translational researchers to interrogate hypoxia-driven metabolic reprogramming and immune evasion in the tumor microenvironment. This article synthesizes mechanistic insight, protocol advice, and strategic guidance, drawing on recent literature and advanced workflow resources to help you drive clinically relevant discoveries in immunometabolism.
-
BHPF as a GPER1 Inhibitor: Mechanistic Insights in Neuroblas
2026-07-16
This study uncovers how fluorene-9-bisphenol (BHPF), a BPA substitute, directly binds and inhibits the G protein-coupled estrogen receptor 1 (GPER1), altering apoptosis pathways in human neuroblastoma cells. The research combines molecular dynamics, mutagenesis, and functional assays to reveal BHPF’s unique interference with GPER1 signaling, distinguishing it from both BPA and classical estrogen response modulators.
-
Hypoxia and Immunometabolism: Mechanisms in Tumor Progressio
2026-07-16
This review dissects how hypoxia and metabolic adaptation drive immune suppression in the tumor microenvironment. By detailing molecular mechanisms and the competitive dynamics for glucose, it highlights strategic opportunities for metabolism-targeted cancer therapies.
-
Optimizing Fluorescent Protein Expression with mCherry mRNA
2026-07-15
EZ Cap™ mCherry mRNA (5mCTP, ψUTP) elevates reporter gene workflows by enhancing mRNA stability, translation, and immune evasion. Discover how this next-gen red fluorescent protein mRNA enables high-fidelity cellular imaging and reliable quantitative assays, even in challenging systems.
-
Octyl-α-ketoglutarate: A Strategic Tool for Hypoxia and IDH
2026-07-15
Explore how Octyl-α-ketoglutarate empowers translational researchers to dissect the interplay between metabolic reprogramming, HIF-1α regulation, and cancer progression—going beyond product pages with mechanistic context, protocol guidance, and translational insights.
-
HotStart™ 2X Green qPCR Master Mix in Translational Oncology
2026-07-14
Discover how HotStart™ 2X Green qPCR Master Mix empowers high-precision SYBR Green qPCR for gene expression analysis in oncology. This article uniquely integrates advanced assay design with recent findings on sunitinib resistance and ferroptosis.
-
Abiraterone Acetate: CYP17 Inhibitor Workflows in 3D Prostat
2026-07-14
Abiraterone acetate empowers prostate cancer researchers with a potent, selective CYP17 inhibitor ideal for dissecting androgen signaling in both 2D and cutting-edge 3D spheroid models. This article delivers stepwise experimental workflows, optimization strategies, and troubleshooting tips to unlock reproducible, translational insights in castration-resistant prostate cancer research.
-
Etomoxir in Fatty Acid Oxidation Pathway Research Protocols
2026-07-13
Etomoxir empowers immunometabolic and metabolic disorder research by enabling precise inhibition of CPT-1 and DGAT, facilitating reproducible modulation of fatty acid oxidation pathways. This article unpacks optimized workflows, troubleshooting insights, and the transformative impact of standardized whole-blood metabolic assays.
-
MOG (35-55) Peptide: Driving Precision in Autoimmune Encepha
2026-07-13
MOG (35-55) Peptide empowers researchers to model multiple sclerosis with unparalleled reproducibility, supporting mechanistic and therapeutic studies in neuroinflammation. Recent advances, including targeted PARP7 inhibition, unlock novel assay readouts and disease-modifying strategies in EAE workflows.
-
Wnt and BMP Patterning of Hemichordate Neuroectoderm: Insigh
2026-07-12
This study delineates how Wnt and BMP signaling pathways establish the anterior neuroectoderm (ANE) in the indirect-developing hemichordate Ptychodera flava. By mapping gene expression and pathway function during gastrulation, the research clarifies evolutionary conservation and divergence in deuterostome axis patterning, offering a comparative framework for developmental and translational biology.